News
Registration opens for London 2019 Conference
9 August 2018
Registration for the HRI London 2019 is now open. The Homeopathy Research Institute’s 4th International Research Conference, ‘Cutting Edg...
More
Hear from the experts
Clinical benefits of individualised homeopathy for menopausal women with depression
Dr Emma Macías-Cortés discusses the remarkable results of a high quality double-blind, double-dummy superiority trial, comparing three test groups receiving homeopathy or fluoxetine or placebo, demonstrating the clinical benefits of individualised homeopathy for peri- and post-menopausal women with depression.
Hot off the press
Polar dyes can be used to detect the presence of homeopathic preparations Open Access
Cartwright, Steven J
Homeopathy 2018; 107(01): 019-031. doi: 10.1055/s-0037-1617448
In the news
EASAC statement on homeopathy
The European Academies’ Scientific Advisory Council (EASAC) recently published a statement on Homeopathic products and practices, the analysis and conclusions of which were based on supposedly ‘excellent science-based assessments already published by authoritative and impartial bodies.’
In the news
HRI submission to public consultation by NHS England
HRI provided input to the public consultation on NHS England’s proposal to ban homeopathic medicines. To date, NHS England has not responded to HRI on any of the points raised in this submission. The legality of NHS England’s decision to go ahead with the ban is now being challenged by patients via their representative charity, the British Homeopathic Association.
Evidence base highlight
High dilutions of taxane drugs alter cell gene expression in vitro
Şeker S, Güven C, Akçakaya H, Bahtiyar N, et al.
Homeopathy, 2018;107(1):32-39
Abstract
